SpringWorks shareholders vote to approve merger with Merck KGaA, Darmstadt

SpringWorks Therapeutics, Inc.

Merger Agreement adopted with 58,902,428 votes For (99.85% of votes cast), 89,192 Against, 11,800 Abstain.
Advisory compensation proposal approved with 54,818,866 For, 3,955,516 Against, 229,038 Abstain.
Special meeting had 78.31% quorum (59,003,420 shares of 75,348,995 outstanding).
Adjournment proposal not voted on as sufficient votes existed for the merger.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.